ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis)
ADIRA
1 other identifier
interventional
56
1 country
1
Brief Summary
Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects 0.5-1% of the population, and where many patients in spite of modern pharmacological treatment fail to reach remission. The main goal of the randomized cross-over trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis) is to test the hypothesis that a diet intervention will decrease disease activity and improve quality of life in patients with established RA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable rheumatoid-arthritis
Started Feb 2017
Shorter than P25 for not_applicable rheumatoid-arthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2016
CompletedFirst Posted
Study publicly available on registry
October 21, 2016
CompletedStudy Start
First participant enrolled
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 9, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 9, 2018
CompletedOctober 15, 2024
October 1, 2024
1.3 years
October 17, 2016
October 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in disease activity score DAS28 (ie a composite score including tender and swollen joints count, ESR or CRP, VAS scale global health) between the two diet interventions, within each person
Measured clinically
10 weeks of each diet
Secondary Outcomes (5)
Difference in SF-36 between the two diet interventions, within each person
10 weeks on each diet
Difference and changes in metabolites between the two diet interventions, within each person
10 weeks on each diet
Differences in inflammatory markers between the two diet interventions, within each person
10 weeks on each diet
Difference in EQ5D between the two diet interventions, within each person
10 weeks on each diet
Difference in HAQ between the two diet interventions, within each person
10 weeks on each diet
Other Outcomes (4)
Cost effectiveness of study intervention by Health-related quality of life
10 weeks on each diet
Cost effectiveness of study intervention by QALYs
10 weeks on each diet
Changes in blood lipids between the two diet interventions, within each person
10 weeks on each diet
- +1 more other outcomes
Study Arms (2)
Fiber diet
EXPERIMENTAL50% of daily intake, 5 days a week, a diet rich in fiber, fish and probiotics will be provided to study subjects
Protein diet
ACTIVE COMPARATOR50% of daily intake, 5 days a week, a diet rich in protein, red meat and saturated fat will be provided to study subjects
Interventions
Foods will be delivered with a home delivery chain once a week for 10 wks of each diet
Foods will be delivered with a home delivery chain once a week for 10 wks of each diet
Eligibility Criteria
You may qualify if:
- Subjects with established RA, disease duration \>2 years, disease activity DAS28 \>= 2.6 and a disease that is clinically stable and under adequate control and medication, will be invited to participate.
You may not qualify if:
- Other life threatening diseases, pregnancy, lactation, food intolerance or allergy to food included in the trial, ability to understand information in Swedish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Göteborg Universitylead
- Sahlgrenska University Hospitalcollaborator
Study Sites (1)
The University of Gothenburg
Gothenburg, 40530, Sweden
Related Publications (6)
Winkvist A, Barebring L, Gjertsson I, Ellegard L, Lindqvist HM. A randomized controlled cross-over trial investigating the effect of anti-inflammatory diet on disease activity and quality of life in rheumatoid arthritis: the Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA) study protocol. Nutr J. 2018 Apr 20;17(1):44. doi: 10.1186/s12937-018-0354-x.
PMID: 29678183BACKGROUNDBarebring L, Winkvist A, Gjertsson I, Lindqvist HM. Poor Dietary Quality Is Associated with Increased Inflammation in Swedish Patients with Rheumatoid Arthritis. Nutrients. 2018 Oct 18;10(10):1535. doi: 10.3390/nu10101535.
PMID: 30340316RESULTWadell AT, Barebring L, Hulander E, Gjertsson I, Landberg R, Lindqvist H, Winkvist A. Dietary biomarkers and food records indicate compliance to study diets in the ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis) trial. Front Nutr. 2023 Jun 22;10:1209787. doi: 10.3389/fnut.2023.1209787. eCollection 2023.
PMID: 37426179DERIVEDTuresson Wadell A, Barebring L, Hulander E, Gjertsson I, Lindqvist HM, Winkvist A. Inadequate Dietary Nutrient Intake in Patients With Rheumatoid Arthritis in Southwestern Sweden: A Cross-Sectional Study. Front Nutr. 2022 Jun 21;9:915064. doi: 10.3389/fnut.2022.915064. eCollection 2022.
PMID: 35799579DERIVEDHulander E, Barebring L, Turesson Wadell A, Gjertsson I, Calder PC, Winkvist A, Lindqvist HM. Diet intervention improves cardiovascular profile in patients with rheumatoid arthritis: results from the randomized controlled cross-over trial ADIRA. Nutr J. 2021 Jan 23;20(1):9. doi: 10.1186/s12937-021-00663-y.
PMID: 33485336DERIVEDVadell AKE, Barebring L, Hulander E, Gjertsson I, Lindqvist HM, Winkvist A. Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA)-a randomized, controlled crossover trial indicating effects on disease activity. Am J Clin Nutr. 2020 Jun 1;111(6):1203-1213. doi: 10.1093/ajcn/nqaa019.
PMID: 32055820DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Winkvist, PhD
Göteborg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2016
First Posted
October 21, 2016
Study Start
February 1, 2017
Primary Completion
May 9, 2018
Study Completion
May 9, 2018
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
Not approved by the Ethical Review board